CN Patent
CN117567388B — 一种2-乙酰基-5-噻唑甲酸的合成方法
Assigned to Jinan Enlighten Biotechnology Co ltd · Expires 2024-04-16 · 2y expired
What this patent protects
本发明属于有机合成技术领域,具体涉及一种2‑乙酰基‑5‑噻唑甲酸的合成方法。本发明以硫脲和正丙醛为起始原料合成2‑乙酰基‑5‑噻唑甲酸,本发明所提供的合成方法,操作简单、产生的三废较少、收率以及产品的品质高,适合工业化生产。
USPTO Abstract
本发明属于有机合成技术领域,具体涉及一种2‑乙酰基‑5‑噻唑甲酸的合成方法。本发明以硫脲和正丙醛为起始原料合成2‑乙酰基‑5‑噻唑甲酸,本发明所提供的合成方法,操作简单、产生的三废较少、收率以及产品的品质高,适合工业化生产。
Drugs covered by this patent
- Ojemda (TOVORAFENIB) · Day One Biopharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.